These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8989162)

  • 1. Use of secretory leukoprotease inhibitor to augment lung antineutrophil elastase activity.
    Vogelmeier C; Gillissen A; Buhl R
    Chest; 1996 Dec; 110(6 Suppl):261S-266S. PubMed ID: 8989162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis.
    McElvaney NG; Doujaiji B; Moan MJ; Burnham MR; Wu MC; Crystal RG
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1056-60. PubMed ID: 8105734
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recombinant secretory leukoprotease inhibitor augments glutathione levels in lung epithelial lining fluid.
    Gillissen A; Birrer P; McElvaney NG; Buhl R; Vogelmeier C; Hoyt RF; Hubbard RC; Crystal RG
    J Appl Physiol (1985); 1993 Aug; 75(2):825-32. PubMed ID: 7901193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aerosolization of recombinant SLPI to augment antineutrophil elastase protection of pulmonary epithelium.
    Vogelmeier C; Buhl R; Hoyt RF; Wilson E; Fells GA; Hubbard RC; Schnebli HP; Thompson RC; Crystal RG
    J Appl Physiol (1985); 1990 Nov; 69(5):1843-8. PubMed ID: 2272977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor.
    Vogelmeier C; Hubbard RC; Fells GA; Schnebli HP; Thompson RC; Fritz H; Crystal RG
    J Clin Invest; 1991 Feb; 87(2):482-8. PubMed ID: 1671391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor.
    McElvaney NG; Nakamura H; Birrer P; Hébert CA; Wong WL; Alphonso M; Baker JB; Catalano MA; Crystal RG
    J Clin Invest; 1992 Oct; 90(4):1296-301. PubMed ID: 1357002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intravenous recombinant secretory leukoprotease inhibitor augments antineutrophil elastase defense.
    Birrer P; McElvaney NG; Gillissen A; Hoyt RF; Bloedow DC; Hubbard RC; Crystal RG
    J Appl Physiol (1985); 1992 Jul; 73(1):317-23. PubMed ID: 1354669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of native and oxidation-resistant secretory leukoprotease inhibitor on cystic fibrosis sputum: inhibition of neutrophil elastase activity and of sputum-induced secretion from porcine tracheal submucosal glands.
    Schuster A; Hansen G; Zubrod-Eichert C; Wahn V
    Pediatr Res; 1996 Nov; 40(5):732-7. PubMed ID: 8910939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secretory leukoprotease inhibitor: partnering alpha 1-proteinase inhibitor to combat pulmonary inflammation.
    Bingle L; Tetley TD
    Thorax; 1996 Dec; 51(12):1273-4. PubMed ID: 8994529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary deposition and disappearance of aerosolised secretory leucocyte protease inhibitor.
    Stolk J; Camps J; Feitsma HI; Hermans J; Dijkman JH; Pauwels EK
    Thorax; 1995 Jun; 50(6):645-50. PubMed ID: 7638807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Therapy of lung diseases with antiproteases].
    Vogelmeier C; Buhl R
    Pneumologie; 1994 Feb; 48(2):57-62. PubMed ID: 7910401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative loss of activity of recombinant secretory leukoprotease inhibitor and alpha 1-protease inhibitor caused by different forms of oxidative stress.
    Vogelmeier C; Biedermann T; Maier K; Mazur G; Behr J; Krombach F; Buhl R
    Eur Respir J; 1997 Sep; 10(9):2114-9. PubMed ID: 9311513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis.
    Birrer P; McElvaney NG; Rüdeberg A; Sommer CW; Liechti-Gallati S; Kraemer R; Hubbard R; Crystal RG
    Am J Respir Crit Care Med; 1994 Jul; 150(1):207-13. PubMed ID: 7912987
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant human secretory leukocyte-protease inhibitor: in vitro properties, and amelioration of human neutrophil elastase-induced emphysema and secretory cell metaplasia in the hamster.
    Lucey EC; Stone PJ; Ciccolella DE; Breuer R; Christensen TG; Thompson RC; Snider GL
    J Lab Clin Med; 1990 Feb; 115(2):224-32. PubMed ID: 2299266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secretory leukocyte protease inhibitor in cystic fibrosis.
    Stromatt SC
    Agents Actions Suppl; 1993; 42():103-10. PubMed ID: 8102834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential role of recombinant secretory leucoprotease inhibitor in the prevention of neutrophil mediated matrix degradation.
    Llewellyn-Jones CG; Lomas DA; Stockley RA
    Thorax; 1994 Jun; 49(6):567-72. PubMed ID: 7912452
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva.
    Masuda K; Suga T; Takeuchi A; Kanesaki M; Imaizumi A; Suzuki Y
    Biochem Pharmacol; 1994 Aug; 48(4):651-7. PubMed ID: 8080437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretory leucocyte proteinase inhibitor: inhibition of fibronectin degradation by neutrophil elastase.
    Gervaix A; Thompson R; Bieth JG; Nick HP; Suter S
    Eur Respir J; 1992 May; 5(5):566-75. PubMed ID: 1351853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of fluticasone on the elastase:antielastase profile of the normal lung.
    Kamal AM; Corrigan CJ; Tetley TD; Alaghband-Zadeh J; Smith SF
    Eur J Clin Invest; 2002 Sep; 32(9):713-9. PubMed ID: 12486873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of secretory leukocyte proteinase inhibitor (SLPI) production by human bronchial epithelial cells: increase of cell-associated SLPI by neutrophil elastase.
    van Wetering S; van der Linden AC; van Sterkenburg MA; Rabe KF; Schalkwijk J; Hiemstra PS
    J Investig Med; 2000 Sep; 48(5):359-66. PubMed ID: 10979241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.